Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Finasteride may help reduce impulsivity caused by pramipexole.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Nanocarriers in gel may reduce side effects of oral hair loss treatments.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Marine sponges from Tabuhan Island can inhibit enzymes linked to Alzheimer's and hair loss.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Cationic polymers improved liposome stability and increased skin absorption of aciclovir and minoxidil.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Analog 23 is a promising compound for prostate cancer treatment.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Finasteride may help improve certain brain function issues linked to dopamine.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Finasteride crystals are held together by hydrogen bonds and weak interactions, forming synthon pseudopolymorphs.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

These new skin treatments are safer and more effective with minimal side effects.